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Background
To critically review publications relating to the diagnosis
of joint hypermobility and instability and discuss an evi-
dence-based approach to children presenting with joint
hypermobility.
Methods
Papers with an emphasis on the diagnosis of joint hyper-
mobility including Heritable Disorders of Connective Tis-
sue (HDCT) in which joint hypermobility is a prominent
feature were identified.
Results
3330 papers were identified, 1534 of which pertain to
instability of a particular joint. 1666 papers related to the
diagnosis of Ehlers Danlos syndromes and a further 330
to joint hypermobility.
Conclusion
There are inconsistencies in the literature on joint hyper-
mobility and how it relates to and overlaps with the
milder forms of HDCT. There is no clear and reliable
method of differentiating between "Joint Hypermobility
Syndrome", familial articular hypermobility and Ehlers-
Danlos syndrome (hypermobile type). These three disor-
ders may, in fact be the same. We have described our
approach to a child presenting with joint hypermobility
and the expert opinion and published evidence from
which this has developed.
We conclude that there is value in both clearly identifying
the underlying genetic cause of an individual child's joint
hypermobility as well as identifying those hypermobile
children who have symptoms such as pain and fatigue
and would benefit from multidisciplinary rehabilitation
management.
We recommend that the term "Joint Hypermobility Syn-
drome" should be reserved to describe symptom(s) which
are complications of joint hypermobility. We use this
term in children who have symptomatic joint hypermo-
bility irrespective of the underlying HDCT.
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